Triple
T19331796
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Fosun Pharma |
E483513
|
entity |
| Predicate | hasSubsidiary |
P254
|
FINISHED |
| Object | Fosun Kite Biotechnology |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Fosun Kite Biotechnology | Statement: [Fosun Pharma, hasSubsidiary, Fosun Kite Biotechnology]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Fosun Kite Biotechnology Context triple: [Fosun Pharma, hasSubsidiary, Fosun Kite Biotechnology]
-
A.
Fosun Pharma
Fosun Pharma is a major Chinese pharmaceutical and healthcare company engaged in the research, development, manufacturing, and distribution of a wide range of medical products and services.
-
B.
Fosun International
Fosun International is a major Chinese multinational conglomerate with diversified investments spanning sectors such as finance, healthcare, tourism, and consumer products.
-
C.
Transigen
Transigen is a secretive biotech corporation in the X-Men/Logan universe that conducts unethical genetic experiments to create and control mutant weapons.
-
D.
Sinopharm
Sinopharm is a Chinese state-owned pharmaceutical company best known globally for developing and distributing inactivated COVID-19 vaccines.
-
E.
Samsung Biologics
Samsung Biologics is a South Korean biopharmaceutical company specializing in contract development and manufacturing (CDMO) of biologic drugs for global pharmaceutical and biotech firms.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Fosun Kite Biotechnology Target entity description: Fosun Kite Biotechnology is a Chinese biopharmaceutical company specializing in the research, development, and commercialization of innovative cell therapies, particularly CAR-T treatments for cancer.
-
A.
Fosun Pharma
chosen
Fosun Pharma is a major Chinese pharmaceutical and healthcare company engaged in the research, development, manufacturing, and distribution of a wide range of medical products and services.
-
B.
Fosun International
Fosun International is a major Chinese multinational conglomerate with diversified investments spanning sectors such as finance, healthcare, tourism, and consumer products.
-
C.
Transigen
Transigen is a secretive biotech corporation in the X-Men/Logan universe that conducts unethical genetic experiments to create and control mutant weapons.
-
D.
Sinopharm
Sinopharm is a Chinese state-owned pharmaceutical company best known globally for developing and distributing inactivated COVID-19 vaccines.
-
E.
Samsung Biologics
Samsung Biologics is a South Korean biopharmaceutical company specializing in contract development and manufacturing (CDMO) of biologic drugs for global pharmaceutical and biotech firms.
- F. None of above.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8e8d13e3c81909d91d1d5ec37c095 |
completed | April 10, 2026, 12:10 p.m. |
| NER | Named-entity recognition | batch_69e616422fa08190bf4bde4312ec7cf3 |
completed | April 20, 2026, 12:04 p.m. |
Created at: April 10, 2026, 1:33 p.m.